Journal of the American Geriatrics Society

Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia

Journal of the American Geriatrics Society

Gregory M. Ouellet, John R. O'Leary, Christopher G. Leggett, Jonathan Skinner, Mary E. Tinetti, Andrew B. Cohen

Although the potential benefits of anticoagulation for AF diminish as individuals with dementia develop more profound cognitive and functional loss, guidelines currently provide little guidance about when to consider discontinuation. This study provides valuable information to clinicians and surrogate decision-makers as they discuss whether to continue anticoagulation in patients with advanced dementia, who have high dementia-related mortality and for whom the primary goal is most frequently comfort.

READ MORE

The association between beta-blockers and outcomes in patients with heart failure and concurrent Alzheimer's disease and related dementias

Journal of the American Geriatrics

Lauren Gilstrap, Andrew Cohen, Gregory M. Ouellet, Parag Goyal, Barbara Gladders, Danette Flint, Jonathan Skinner

Background Contemporary patients with heart failure with reduced ejection fraction
(HFrEF) are older and have a higher prevalence of cognitive impairment than those
studied in trials. The risk/benefit trade-off of routine beta-blocker (BB) use in patients …

The Association Between Neurohormonal Therapy and Mortality in Older Adults with Heart Failure With Reduced Ejection Fraction

Journal of the American Geriatrics Society

Lauren Gilstrap, Andrea M. Austin, Barbara Gladders, Parag Goyal, A. James O’Malley, Amber Barnato, Anna N.A, Tosteson, Jonathan S. Skinner

Neurohormonal therapy, which includes beta-blockers and angiotensin-converting enzyme inhibitor/angiotensin receptor blockers (ACEi/ARBs), is the cornerstone of heart failure with reduced ejection fraction (HFrEF) treatment. While neurohormonal therapies have demonstrated efficacy in randomized clinical trials, older patients, which now comprise the majority of HFrEF patients, were underrepresented in those original trials. This study aimed to determine the association between short- (30 day) and long-term (1 year) mortality and the use of neurohormonal therapy in HFrEF patients, across the age spectrum.

READ MORE

Residential Setting and the Cumulative Financial Burden of Dementia in the 7  Years Before Death

Journal of the American Geriatric Society
Kelley AS, McGarry K, Bollens-Lund E, Rahman OK, Husain M, Ferreira KB, Skinner JS.

Care for older adults with dementia during the final years of life is costly, and families shoulder much of this burden. We aimed to assess the financial burden of care for those with and without dementia, and to explore differences across residential settings. Using the Health and Retirement Study (HRS) and linked claims, we examined total healthcare spending and proportion by payer-Medicare, Medicaid, out-of-pocket, and calculated costs of informal caregiving-over the last 7 years of life, comparing those with and without dementia and stratifying by residential setting. We found that, consistent with prior studies, people with dementia experience significantly higher costs, with a disproportionate share falling on patients and families. This pattern is most striking among community residents with dementia, whose families shoulder 64% of total expenditures (including $176,180 informal caregiving costs and $55,550 out-of-pocket costs), compared with 43% for people with dementia residing in nursing homes ($60,320 informal caregiving costs and $105,590 out-of-pocket costs). These findings demonstrate disparities in financial burden shouldered by families of those with dementia, particularly among those residing in the community. They highlight the importance of considering the residential setting in research, programs, and policies.

READ MORE

Exnovation of Low Value Care: A Decade of Prostate-Specific Antigen Screening Practices

Journal of the American Geriatrics Society
Julie Bynum, MD, MPH, Honor Passow, PhD, Donald Carmichael, MDiv, and Jonathan Skinner, PhD

Using PSA screening, we aimed to understand which factors influence practice change during a period when a decline in service use would be expected. First, we focused on national PSA screening in men aged 68 and older with fee-for-service Medicare from 2003 to 2013 and examine the influence of guidelines by assessing changes in likelihood of screening associated with factors directly mentioned in guidelines. Second, we focused on practice change across U.S. hospital referral regions (HRRs) for men aged 75 and older – for whom guidelines have been in agreement – to test whether practice variation declines and what contextual factors are associated with greater decline. We hypothesized that guidelines and the practice environment would influence the degree to which practitioners and patients would reduce their use of an existing practice in the face of converging evidence regarding effectiveness.

READ MORE